Home › Pharma, Biotech IP Counsel Expect a Litigious Year
 

Keywords :   


Pharma, Biotech IP Counsel Expect a Litigious Year

2013-03-14 10:49:35| Biotech - Topix.net

Nearly half of the chief IP counsel working in the pharmaceutical and biotech industries who participated in a new survey indicated that their companies are currently involved in patent infringement litigation-and 43 percent said there was a 'very high' likelihood that they would file a claim for patent infringement in the year ahead.

Tags: year expect counsel biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Ex-cabinet secretary says 200,000 job is underpaid
06.10Hurricane Leslie Graphics
06.10Hurricane Leslie Forecast Discussion Number 16
06.10Hurricane Leslie Wind Speed Probabilities Number 16
06.10Hurricane Leslie Forecast Advisory Number 16
06.10Hurricane Leslie Public Advisory Number 16
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Kirk Graphics
More »